Greenwich LifeSciences, Inc. (GLSI) vs Utah Medical Products, Inc. (UTMD)
A side-by-side comparison of Greenwich LifeSciences, Inc. and Utah Medical Products, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GLSI
Greenwich LifeSciences, Inc.
$16.19HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
UTMD
Utah Medical Products, Inc.
$73.96HealthcareDelayed quote: Oct 6, 2026, 3:30 PM EDT
Total return — GLSI vs UTMD
growth of $100 · dividends reinvested · last 6yGLSI +238.2% (+22.5%/yr)UTMD -0.9% (-0.1%/yr)GLSI compounded faster over this window
GLSI UTMD
GLSI vs UTMD: by the numbers
- •GLSI is the larger company ($238M vs $235M market cap).
- •UTMD is profitable (29.04% net margin) while GLSI runs a net loss (0.00%).
- •UTMD pays a dividend (1.67% yield), while GLSI has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | GLSI | UTMD |
|---|---|---|
| P/E ratio | N/A | 22.55 |
| PEG ratio | N/A | 6.57 |
| P/S ratio | N/A | 6.52 |
| P/B ratio | 76.24 | 1.93 |
| EV / EBITDA | N/A | 18.58 |
| FCF yield | N/A | 4.86% |
Profitability
| Metric | GLSI | UTMD |
|---|---|---|
| Gross margin | 0.00% | 54.88% |
| Operating margin | 0.00% | 28.46% |
| Net margin | 0.00% | 29.04% |
| ROE | -695.56% | 8.59% |
| ROIC | -701.55% | 6.83% |
Dividends
| Metric | GLSI | UTMD |
|---|---|---|
| Dividend yield | N/A | 1.67% |
| Payout ratio | N/A | 37.80% |
Growth (annualized)
| Metric | GLSI | UTMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -4.75% |
| EPS CAGR (5Y) | N/A | 3.36% |
| FCF CAGR (5Y) | N/A | -11.12% |
| Total return CAGR (5Y) | -14.84% | -2.70% |
Frequently asked
- Does GLSI or UTMD pay a bigger dividend?
- UTMD pays a dividend (1.67% yield), while GLSI has no payments in the available dividend history.
- Is GLSI or UTMD more profitable?
- UTMD runs the higher net margin — GLSI at 0.00% versus UTMD at 29.04%.
- How have GLSI and UTMD total returns compared?
- Over the past 5 years, GLSI delivered -14.84% and UTMD delivered -2.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Utah Medical Products P/E ratioUtah Medical Products dividend yieldGreenwich LifeSciences ROEUtah Medical Products ROEGreenwich LifeSciences operating marginUtah Medical Products operating marginGreenwich LifeSciences revenue growthUtah Medical Products revenue growthGreenwich LifeSciences free cash flowUtah Medical Products free cash flow
Greenwich LifeSciences & Utah Medical Products appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.